semaglutide cardiovascular outcomes news 2025 october Semaglutide treatment reduces heart failure risks Semaglutide lowers cardiovascular events even

This injectable targets GLP-1 and GIP receptors for maximal efficacy, achieving up to a 20.9% body weight reduction in trials

Toxic effects of carbon quantum dots on the gutliver axis and gut microbiota in the common carp cyprinus carpio

What makes these capsules unique is that the glutathione is encapsulated within tiny lipid spheres called liposomes

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study

This is the critical window for prevention

Major players like Novo Nordisk, Eli Lilly, and AstraZeneca are making strategic investments